Biomaterials for Drugs Nose–Brain Transport: A New Therapeutic Approach for Neurological Diseases
In the last years, neurological diseases have resulted in a global health issue, representing the first cause of disability worldwide. Current therapeutic approaches against neurological disorders include oral, topical, or intravenous administration of drugs and more invasive techniques such as surg...
Main Authors: | Roberta Cassano, Camilla Servidio, Sonia Trombino |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Materials |
Subjects: | |
Online Access: | https://www.mdpi.com/1996-1944/14/7/1802 |
Similar Items
-
Micro- and Nanosized Carriers for Nose-to-Brain Drug Delivery in Neurodegenerative Disorders
by: Radka Boyuklieva, et al.
Published: (2022-07-01) -
Nose-to-Brain: The Next Step for Stem Cell and Biomaterial Therapy in Neurological Disorders
by: Natalia Villar-Gómez, et al.
Published: (2022-10-01) -
Paraoxonases at the Heart of Neurological Disorders
by: Fatimah K. Khalaf, et al.
Published: (2023-04-01) -
Preventive effect of nasal Timosaponin BII-loaded temperature-/ion-sensitive in situ hydrogels on Alzheimer’s disease
by: Ge Ou, et al.
Published: (2021-01-01) -
Nose-to Brain Direct Delivery of Nanodrug Formulations in Treatment of Neurological Disorders: A Review Study
by: Sara Assadpour, et al.
Published: (2021-04-01)